X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73
https://www.business-standard.com/article/news-cm/zydus-receives-usfda-approval-for-erlotinib-tablets-120041700373_1.html
https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-gets-final-approval-from-usfda-for-cancer-drug-but-share-price-falls-3-5159061.html
https://www.prnewswire.com/news-releases/armas-pharmaceuticals-announces-launch-of-oncology-generic-erlotinib-300956958.html
https://www.biopharmadive.com/news/meet-the-protein-responsible-for-nearly-100b-in-cancer-drug-deals/561097/
http://www.pmlive.com/pharma_news/tagrisso_tops_rival_drugs_on_survival_in_first-line_lung_cancer_1296900
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210300
https://www.fiercepharma.com/pharma/nice-shuts-down-az-s-tagrisso-and-backs-pfizer-rival-vizimpro-instead?utm_source=internal&utm_medium=rss
https://www.fiercebiotech.com/research/how-a-long-known-biomarker-backs-biontech-antibody-s-case-for-pancreatic-cancer
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208396
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211083
https://www.in-pharmatechnologist.com/Article/2019/05/20/Generic-NSCLC-treatment-launched-by-Teva
https://www.prnewswire.com/news-releases/mylan-expands-oncology-portfolio-with-launch-of-generic-tarceva-tablets-300848059.html
https://endpts.com/with-alimta-patent-cliff-looming-lilly-plots-stronger-foothold-in-frontline-nsclc-with-cyramza/
https://endpts.com/betting-on-allosteric-mutations-driving-cancer-black-diamond-raises-85m-in-fresh-round/
https://www.raps.org/news-and-articles/news-articles/2018/12/fda-drafts-guidance-on-oncology-companion-diagnost?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%207%20December
https://www.fiercebiotech.com/medtech/fda-approves-roche-s-cobas-egfr-blood-test-as-a-companion-diagnostic-for-az-s-iressa
https://www.prnewswire.com/news-releases/amneal-launches-budesonide-capsules-300584552.html
http://www.pmlive.com/pharma_news/clock_starts_ticking_on_azs_first-line_lung_cancer_filing_in_us_1214772
http://www.pharmatimes.com/news/lillys_verzenio_misses_key_survival_goal_in_lung_cancer_1207947
http://www.nasdaq.com/article/astellas-pharma-to-discontinue-asp8273-treatment-arm-in-latestage-solar-trial-20170510-01889
http://www.fiercebiotech.com/research/cancer-drugs-tarceva-and-sutent-hold-ebola-and-dengue-at-bay-mice
http://www.biospace.com/News/genentechs-94000-a-year-drug-tarceva-why-faster/446013/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.prnewswire.com/news-releases/genprex-announces-positive-interim-data-from-phase-ii-clinical-trial-of-oncoprex-for-late-stage-non-small-cell-lung-cancer-300386946.html
http://www.prnewswire.com/news-releases/bioniz-therapeutics-appoints-paul-frohna-md-phd-pharm-d-as-senior-vice-president-of-clinical-development-300381733.html
http://www.reuters.com/article/us-astrazeneca-cancer-pill-idUSKBN13V0VH
https://www.bloomberg.com/news/articles/2016-11-29/pharma-ceo-pursues-new-trophy-to-top-prostate-cancer-blockbuster
http://www.fiercepharma.com/pharma/icer-calls-for-deep-discounts-for-opdivo-keytruda-tarceva-others-nsclc
http://www.pharmatimes.com/news/eu_nod_for_avastintarceva_lung_cancer_combo_1037308
https://www.statnews.com/pharmalot/2016/06/06/drug-makers-pay-67m-misleading-docs-cancer-drug-survival-data/
http://www.fiercepharma.com/pharma-asia/astrazeneca-keeps-double-digit-china-growth-track-q1
http://www.pmlive.com/news/regulatory/2016/april/boehringer_ingelheims_giotrif_wins_new_nsclc_licence_in_europe_972872
http://www.fiercepharmaasia.com/story/china-nhfpc-drug-price-pilot-signals-volume-cost-cuts-formula/2016-03-12
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/the-pill-that-costs-9000-in-us-sells-for-70-in-india/articleshow/50886629.cms
http://health.economictimes.indiatimes.com/news/pharma/sc-agrees-to-hear-ciplas-plea-against-la-roche/50752164
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/56720a-eng.php
http://www.business-standard.com/article/companies/roche-glenmark-settles-patent-dispute-on-tarceva-116010100335_1.html
http://www.pharmatimes.com/Article/15-12-21/93_medicines_recommended_by_CHMP_in_2015.aspx
http://www.pmlive.com/pharma_news/uk_patients_get_early_access_to_azs_lung_cancer_drug_tagrisso_883737
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-weighs-legal-options-after-delhi-hcs-patent-ruling/articleshow/49962103.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-upholds-roches-patent-claims-on-tarceva-against-cipla/articleshow/49948468.cms
http://fortune.com/2015/11/20/merck-ceo-drug-prices-turing/?
http://www.fiercepharma.com/story/express-scripts-rolls-out-value-based-pricing-cancer-meds/2015-11-19
http://www.pmlive.com/pharma_news/boehringer_takes_third-generation_nsclc_drug_into_pivotal_trials_857039
http://www.fiercepharma.com/story/us-cancer-drug-prices-3x-higher-europe-study/2015-09-24
http://in.reuters.com/article/2015/09/22/us-health-pharmaceuticals-cancer-usa-idINKCN0RM1EC20150922
http://www.firstwordpharma.com/node/1286782?tsid=28®ion_id=2#axzz3bDbJQOH2
Market Place
Share 
